MBTPS1 and age-related macular degeneration: (2) Reducing S1P levels: recently, new therapeutic approaches using S1P-neutralizing antibody [24] or S1P receptors antagonists [25,26] have been developed and are being tested in clinical trials for cancer and age-related macular degeneration.